Science
Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies
Source: Phys.org · Published
A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application.
Related stories
- Study maps Nelore cattle microbiota to reduce methane emissions
Phys.org · 4 Nov 2026, 01:00
- North Atlantic's 'cold blob' may contain climate nuance
Phys.org · 4 Nov 2026, 00:40
- How the nasal microbiome can help potentially harmful bacteria thrive
Phys.org · 4 Nov 2026, 00:40
- US midterm elections: Younger politicians could strengthen trust in democracy
Phys.org · 4 Nov 2026, 00:20
- Using vibrations to reveal what lies beneath other planets' surfaces
Phys.org · 4 Nov 2026, 00:10
- Tiny fossils show brittle stars gathered around a dead whale 9.5 million years ago
Phys.org · 4 Nov 2026, 00:00
We are a news aggregator: we show the headline and a short excerpt with a link to the original source. We never republish full articles.